Market Industry Reports (MIR) has published a new report titled “Hypopigmentation Disorders Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report, the global hypopigmentation disorders treatment market is anticipated to be over US$ 2.5 Bn by 2030. It is further expected that the market will witness a substantial CAGR from 2019 to 2030.

New York, NY -- (SBWire) -- 04/02/2019 --The Study On Major Key Players in the hypopigmentation Disorders Treatment market are ALLERGAN, SkinCeuticals International, PIERRE FABRE GROUP, Episciences, Inc., RXi Pharmaceuticals, Obagi Cosmeceuticals LLC., and Alvogen among others.

Increasing awareness among patients, technological advancements in the sector of aesthetic treatment of pigmentation related conditions, and growing geriatric population have been pivotal in dictating the growth of the hypopigmentation disorders treatment market. Moreover, increasing incidences of disorders related to hypopigmentation, namely albinism, and vitiligo is anticipated to be the major driver of the global hypopigmentation disorders treatment market between 2019 and 2030.

Download Free Sample Copy@ https://www.marketindustryreports.com/pdf/38

Increasing Incidences of Vitiligo

According to the American Academy of Dermatology, vitiligo is considered to be among 24 skin diseases, which are widely prevalent among the population. Vitiligo is known to affect individuals from all ethnic background and genders equivalently. While, vitiligo can affect people from all ages, but the prevalence of the same is more prominent among individuals between the age 10 and 30 years. Moreover, in 2013, it was estimated that more than 150,000 Americans from all age groups underwent treatment for vitiligo. Rising incidences and prevalence of vitiligo is anticipated to further contribute to the growing demand of the global hypopigmentation disorders treatment market.

Increasing Adoption of Minimally-Invasive Procedures

Since the advent of minimally-invasive procedures, the adoption of such procedures have witnessed substantial growth in recent times. Shorter hospital admittance time, lesser procedure associated pain and fewer complications have been pivotal in contributing to the growing adoption of minimally-invasive procedures. According to the American Society of Plastic Surgeons (ASPS), the numbers of Americans opting for minimally-invasive cosmetic procedures have witnessed a growth of nearly 200% since 2000.  In 2017, the total number of cosmetic procedures performed in U.S. was nearly 1.8 million. Growing preference for minimally-invasive cosmetic procedures in anticipated to further propel the growth of the hypopigmentation disorders treatment market.

Browse key industry insights spread across 150 pages with market data tables & figures & charts from the report,  Hypopigmentation Disorders Treatment Market by Treatment Type (Topical Drugs, Chemical Peels, Laser Therapy, and Microdermabrasion), Disease Indication (Albinism, and Vitiligo), End User (Dermatology Centers, Aesthetic Clinics, and Hospitals) - Global Analysis & Forecast 2019-2030  in detail along with the table of contents:

https://www.marketindustryreports.com/38/hypopigmentation-disorders-treatment-market

Complications and Risk Related Associated with Cosmetic Treatments to Restrain the Market

Various complications and risk related to cosmetic treatments have been major factors that have been affecting the growth of the hypopigmentation disorders treatment industry inversely. Several complications such as nerve damage, infections, seroma and pulmonary embolism are known to cause serious adverse and side effects as a result of different cosmetic or aesthetic treatments. Similarly, patients have reported granulomas, and infections as long-term adverse effects caused as a result of cosmetic treatments.

Rapid Growth of the Asia Pacific Market

Asia Pacific is estimated to witness the highest CAGR during the forecast period. Increasing population, continuously growing economy, increasing healthcare spending, rising medical tourism and increasing awareness regarding cosmetic treatment and growing adoption of latest technologies is anticipated to present a lucrative growth scenario for the hypopigmentation disorders treatment market in this region.

Key Point Of TOC:

COMPANY PROFILES

(Business Overview, Products/Services Offered, Financial Performance*, R&D Intensity, Marketing & Sales Intensity, Recent Developments, Analyst Corner)

 - ALLERGAN
 - SkinCeuticals International 
   - PIERRE FABRE GROUP
   - Episciences, Inc.
   - RXi Pharmaceuticals
   - Obagi Cosmeceuticals LLC.
   - Alvogen

(*Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain)

Get Exclusive Discount @ https://www.marketindustryreports.com/discount/38

About Market Industry Reports
Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.
We continue to pioneer state-of-the-art approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.

Contact Us- 

502, Sai Radhe, Kennedy Road,
Behind Hotel Sheraton Grand,
Near Pune Station, Pune 411 001
Email: sales@marketindustryreports.com
Phone: + 91 967353933
Website: https://www.marketindustryreports.com/
Follow Us- LinkedIn | Twitter | Google+ | Facebook